<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04454242</url>
  </required_header>
  <id_info>
    <org_study_id>2020/09</org_study_id>
    <nct_id>NCT04454242</nct_id>
  </id_info>
  <brief_title>High and Low Intensity Expiratory Muscle Strength Training in Patients With Obstructive Sleep Apnea Syndrome</brief_title>
  <official_title>Comparison of the Effects of High and Low Intensity Expiratory Muscle Strength Training in Patients With Obstructive Sleep Apnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Scientific and Technological Research Council of Turkey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of expiratory muscle strength training (EMST) on sleep quality, disease severity,&#xD;
      and respiratory muscle strength has been previously investigated in OSA syndrom. Only the&#xD;
      effects of the high-intensity short-term EMST study in moderate OSAS patients were studied.&#xD;
      High intensity and low intensity EMST has advantages and disadvantages.The study aims to&#xD;
      compare the effects of high (60% MEP) and low (30% MEP) expiratory muscle strength training&#xD;
      (EMST) on disease severity, sleep efficiency, snoring, fatigue severity and quality of life&#xD;
      in severe OSAS patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ahi Evren Chest Cardiovascular Surgery Training Research Hospital In sleep lab,&#xD;
      polysomnography will be directed to the physiotherapist by the pulmonologist with severe OSAS&#xD;
      patients. Patients will be divided into two groups by block randomization method. The study&#xD;
      was planned as double-blind. Patients will not know what treatment they are receiving, the&#xD;
      doctor does not know what treatment the patient is receiving, and technicians who take and&#xD;
      analyze polysomnography will not know what treatment the patients are receiving.&#xD;
&#xD;
      Severe OSAS patients with MEP 30% (low intensity) to the first group, MEP 60% (high&#xD;
      intensity) to the second group with expiratory muscle training device, 7 days / week, 25&#xD;
      breaths per day, 1 minute rest for 5 breaths will be run with the cycle. The training will&#xD;
      take a total of 8 weeks. The follow-up of the patients will be done remotely by phone. MEP&#xD;
      measurements will be repeated every 2 weeks in the hospital and the new training workload&#xD;
      will be calculated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease severity</measure>
    <time_frame>2 day</time_frame>
    <description>Polysomnography recordings will be taken especially sleep efficiency and apnea-hypopnea index (AHI). Higher sleep efficiency and lower AHI values shows that patient have better status and lower disease severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory muscle strength</measure>
    <time_frame>5 day</time_frame>
    <description>Maximal inspiratory and expiratory muscle strength measurement with mouth pressure device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daytime sleepiness</measure>
    <time_frame>2 day</time_frame>
    <description>Epworth Slepiness Scale (ESS). Minimum and maximum scores: 0-24. The higher ESS score means the higher that person's average sleep propensity in daily life (ASP), or their 'daytime sleepiness'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Snoring severitiy and frequency</measure>
    <time_frame>2 day</time_frame>
    <description>Berlin Questionnaire: Snoring frequency (0-3) and severity (0-4). Higher scores show higher snoring frequency and severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>2 day</time_frame>
    <description>The Pittsburgh Sleep Quality Index (PSQI). Minimum and maximum scores: 0-21. Higher PSQI scores show worse sleep quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue severity.</measure>
    <time_frame>2 day</time_frame>
    <description>Fatigue Severity Scale (FSS) . Minimum and maximum scores: 0-7. FSS scores higher than 4 shows high intensity fatigue perception</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Antropometric measurements</measure>
    <time_frame>2 day</time_frame>
    <description>Neck circumference, Waist circumference, Hip circumference, Waist to hip ratio with circumference measurement method</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>L-EMST</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At 30% of the maximum expiratory pressure (MEP), 25 breaths, 7 days / week, a total of 8 weeks will be trained once a day with a 1-minute rest cycle in 5 breaths.&#xD;
Patients will be invited to control every 2 weeks. MEP measurements will be repeated and the training value will be adjusted in 30% of the new measurement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>H-EMST</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In 60% of the maximum expiratory pressure (MEP), 25 breaths a day, 7 days / week, a total of 8 weeks will be trained with a 1-minute rest cycle in 5 breaths.&#xD;
Patients will be invited to control every 2 weeks. MEP measurements will be repeated and the training value will be adjusted in 60% of the new measurement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Expiratory muscle trainig</intervention_name>
    <description>This exercise will be used to strengthen forced expiratory muscles.</description>
    <arm_group_label>H-EMST</arm_group_label>
    <arm_group_label>L-EMST</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients diagnosed with severe OSAS by Polysomnography in Ahi Evren Chest,&#xD;
             Cardiovascular Surgery Training and Research Hospital Sleep Center will be included.&#xD;
&#xD;
          2. General health condition is stable&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Passed stroke,&#xD;
&#xD;
          2. Neurological disease and psychological disease&#xD;
&#xD;
          3. Cardiac disease&#xD;
&#xD;
          4. Hypothyroidism&#xD;
&#xD;
          5. Serious obstructive nasal disease,&#xD;
&#xD;
          6. A history of infection in the past month.&#xD;
&#xD;
          7. Previous oroferengeal surgery history&#xD;
&#xD;
          8. With a BMI of 40 kg / m2 or more,&#xD;
&#xD;
          9. Using substance, alcohol, sedative and hypnotic drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Calik-Kutukcu, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nurel Erturk, MsC</last_name>
    <phone>+905056637544</phone>
    <email>nrlbllr@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adem Celik, MD</last_name>
    <phone>05072386150</phone>
    <email>drcelikadem@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital</name>
      <address>
        <city>Trabzon</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nurel Erturk, MsC</last_name>
      <phone>+905056637544</phone>
      <email>nrlbllr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Adem Celik, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ebru Calik-Kutukcu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 26, 2020</study_first_submitted>
  <study_first_submitted_qc>June 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>NUREL ERTURK</investigator_full_name>
    <investigator_title>Clinical Physiotherapist</investigator_title>
  </responsible_party>
  <keyword>Expiratory muscle strength training</keyword>
  <keyword>Snoring</keyword>
  <keyword>Sleep quality</keyword>
  <keyword>EMST</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

